These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans. Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308 [TBL] [Abstract][Full Text] [Related]
50. Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 10 determined by NMR spectroscopy. Sheng S; Cherniak R Carbohydr Res; 1997 Dec; 305(1):65-72. PubMed ID: 9534227 [TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. Mukherjee J; Kozel TR; Casadevall A J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877 [TBL] [Abstract][Full Text] [Related]
52. Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans. Ikeda R; Saito F; Matsuo M; Kurokawa K; Sekimizu K; Yamaguchi M; Kawamoto S J Bacteriol; 2007 Jul; 189(13):4815-26. PubMed ID: 17483230 [TBL] [Abstract][Full Text] [Related]
53. Synthesis of a hexasaccharide fragment of the O-deacetylated GXM of C. neoformans serotype B. Zhao W; Kong F Carbohydr Res; 2004 Jul; 339(10):1779-86. PubMed ID: 15220088 [TBL] [Abstract][Full Text] [Related]
54. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327 [TBL] [Abstract][Full Text] [Related]
55. Structural variation in the O-specific polysaccharides of Klebsiella pneumoniae serotype O1 and O8 lipopolysaccharide: evidence for clonal diversity in rfb genes. Kelly RF; Severn WB; Richards JC; Perry MB; MacLean LL; Tomás JM; Merino S; Whitfield C Mol Microbiol; 1993 Nov; 10(3):615-25. PubMed ID: 7526122 [TBL] [Abstract][Full Text] [Related]
56. Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure. Urai M; Kaneko Y; Ueno K; Okubo Y; Aizawa T; Fukazawa H; Sugita T; Ohno H; Shibuya K; Kinjo Y; Miyazaki Y Front Cell Infect Microbiol; 2015; 5():101. PubMed ID: 26779451 [TBL] [Abstract][Full Text] [Related]
57. Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay. Belay T; Cherniak R; Shinoda T Infect Immun; 1993 Jul; 61(7):2879-85. PubMed ID: 7685739 [TBL] [Abstract][Full Text] [Related]
58. The structure of Cryptococcus neoformans galactoxylomannan contains beta-D-glucuronic acid. Heiss C; Klutts JS; Wang Z; Doering TL; Azadi P Carbohydr Res; 2009 May; 344(7):915-20. PubMed ID: 19345342 [TBL] [Abstract][Full Text] [Related]